{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:39:21Z","timestamp":1783406361162,"version":"3.54.6"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.revmed.2021.06.011","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T03:20:39Z","timestamp":1626232839000},"page":"98-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Les m\u00e9ningiomes\u00a0: mise au point sur les connaissances actuelles"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2572-8594","authenticated-orcid":false,"given":"J.","family":"Boetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6781-7301","authenticated-orcid":false,"given":"C.","family":"Birzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kalamarides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-9516","authenticated-orcid":false,"given":"M.","family":"Peyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2021.06.011_bib0305","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013\u20132017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0310","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00701-020-04650-w","article-title":"Meningiomas from a developmental perspective: exploring the crossroads between meningeal embryology and tumorigenesis","volume":"163","author":"Boetto","year":"2021","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.revmed.2021.06.011_bib0315","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","article-title":"Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review","volume":"122","author":"Rogers","year":"2015","journal-title":"J Neurosurg"},{"key":"10.1016\/j.revmed.2021.06.011_bib0320","doi-asserted-by":"crossref","first-page":"n37","DOI":"10.1136\/bmj.n37","article-title":"Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study","volume":"372","author":"Weill","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2021.06.011_bib0325","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0090-3019(87)90005-X","article-title":"Incidental meningiomas in autopsy study","volume":"27","author":"Nakasu","year":"1987","journal-title":"Surg Neurol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0330","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","article-title":"Epidemiology and etiology of meningioma","volume":"99","author":"Wiemels","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0335","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/FOC\/2008\/24\/5\/E7","article-title":"Radiation-induced meningioma","volume":"24","author":"Umansky","year":"2008","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.revmed.2021.06.011_bib0340","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/jmg.2010.085241","article-title":"Cranial meningiomas in 411\u00a0neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset","volume":"48","author":"Smith","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.revmed.2021.06.011_bib0345","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cancergen.2015.02.003","article-title":"Germline and somatic mutations in meningiomas","volume":"208","author":"Smith","year":"2015","journal-title":"Cancer Genet"},{"key":"10.1016\/j.revmed.2021.06.011_bib0350","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M","article-title":"Clinical manifestations in 105\u00a0persons with nevoid basal cell carcinoma syndrome","volume":"69","author":"Kimonis","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.revmed.2021.06.011_bib0355","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/path.4427","article-title":"Germline SMARCE1\u00a0mutations predispose to both spinal and cranial clear cell meningiomas","volume":"234","author":"Smith","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0360","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/neuros\/nyy121","article-title":"Familial Syndromes Involving Meningiomas Provide Mechanistic Insight Into Sporadic Disease","volume":"83","author":"Kerr","year":"2018","journal-title":"Neurosurgery"},{"key":"10.1016\/j.revmed.2021.06.011_bib0365","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016\u00a0World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.revmed.2021.06.011_bib0370","doi-asserted-by":"crossref","first-page":"101562","DOI":"10.1016\/j.canep.2019.07.001","article-title":"Incidence, mortality and outcome of meningiomas: A population-based study from Germany","volume":"62","author":"Holleczek","year":"2019","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0375","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/neuonc\/nov177","article-title":"A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma","volume":"18","author":"Aizer","year":"2016","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0380","doi-asserted-by":"crossref","first-page":"14719","DOI":"10.1073\/pnas.94.26.14719","article-title":"Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression","volume":"94","author":"Weber","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.revmed.2021.06.011_bib0385","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14433","article-title":"Integrated genomic analyses of de novo pathways underlying atypical meningiomas","volume":"8","author":"Harmanc\u0131","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.revmed.2021.06.011_bib0390","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1158\/1078-0432.CCR-10-0891","article-title":"Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2\u00a0status","volume":"16","author":"Goutagny","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.revmed.2021.06.011_bib0395","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0002-9440(10)61737-3","article-title":"Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas","volume":"159","author":"Bostr\u00f6m","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0400","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2017.168","article-title":"Advances in meningioma genetics: novel therapeutic opportunities","volume":"14","author":"Preusser","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0405","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12964-020-00544-7","article-title":"Merlin regulates signaling events at the nexus of development and cancer","volume":"18","author":"Mota","year":"2020","journal-title":"Cell Commun Signal CCS"},{"key":"10.1016\/j.revmed.2021.06.011_bib0410","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2\u00a0meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.revmed.2021.06.011_bib0415","first-page":"1","article-title":"Correlations between genomic subgroup and clinical features in a cohort of more than 3000\u00a0meningiomas","author":"Youngblood","year":"2019","journal-title":"J Neurosurg"},{"key":"10.1016\/j.revmed.2021.06.011_bib0420","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv377","article-title":"TERT Promoter Mutations and Risk of Recurrence in Meningioma","volume":"108","author":"Sahm","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.revmed.2021.06.011_bib0425","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/bpa.12110","article-title":"High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression","volume":"24","author":"Goutagny","year":"2014","journal-title":"Brain Pathol Zurich Switz"},{"key":"10.1016\/j.revmed.2021.06.011_bib0430","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/neuonc\/noz061","article-title":"DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management","volume":"21","author":"Nassiri","year":"2019","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0435","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00401-017-1678-x","article-title":"Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma","volume":"133","author":"Olar","year":"2017","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.revmed.2021.06.011_bib0440","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0445","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00401-018-1844-9","article-title":"Loss of histone H3K27me3\u00a0identifies a subset of meningiomas with increased risk of recurrence","volume":"135","author":"Katz","year":"2018","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.revmed.2021.06.011_bib0450","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng.2526","article-title":"Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1\u00a0mutations","volume":"45","author":"Brastianos","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2021.06.011_bib0455","doi-asserted-by":"crossref","first-page":"e1261","DOI":"10.1016\/j.wneu.2018.03.187","article-title":"Case Report and Literature Review of Pregnancy-Associated Meningioma","volume":"114","author":"Chakravarthy","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.revmed.2021.06.011_bib0460","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3171\/2014.12.JNS142112","article-title":"Hormone-dependent shrinkage of a sphenoid wing meningioma after pregnancy: case report","volume":"124","author":"Kerschbaumer","year":"2016","journal-title":"J Neurosurg"},{"key":"10.1016\/j.revmed.2021.06.011_bib0465","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.wneu.2020.04.168","article-title":"New Insights into Expression of Hormonal Receptors by Meningiomas","volume":"140","author":"Portet","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.revmed.2021.06.011_bib0470","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/cncr.10410","article-title":"The association between breast carcinoma and meningioma in women","volume":"94","author":"Custer","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.revmed.2021.06.011_bib0475","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/sj.bjc.6604445","article-title":"Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort","volume":"99","author":"Benson","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.revmed.2021.06.011_bib0480","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1002\/ijc.29274","article-title":"Menopausal hormone therapy and central nervous system tumor risk: large UK prospective study and meta-analysis","volume":"136","author":"Benson","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.revmed.2021.06.011_bib0485","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1200\/JCO.2007.14.2133","article-title":"Is there an association between meningioma and hormone replacement therapy?","volume":"26","author":"Blitshteyn","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0490","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00003495-200363050-00003","article-title":"Progestogens with antiandrogenic properties","volume":"63","author":"Raudrant","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.revmed.2021.06.011_bib0495","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00701-015-2532-3","article-title":"Growth stabilization and regression of meningiomas after discontinuation of cyproterone acetate: a case series of 12\u00a0patients","volume":"157","author":"Bernat","year":"2015","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.revmed.2021.06.011_bib0500","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11060-021-03696-9","article-title":"Evolution of the neurosurgical management of progestin-associated meningiomas: a 23-year single-center experience","volume":"152","author":"Malaize","year":"2021","journal-title":"J Neurooncol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0505","unstructured":"Ac\u00e9tate de cyprot\u00e9rone (Androcur et ses g\u00e9n\u00e9riques) et risque de m\u00e9ningiome\u00a0: R\u00e9sultats de l\u2019enqu\u00eate de pharmacovigilance - Point d\u2019Information - ANSM\u00a0: Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 n.d. https:\/\/www.ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Acetate-de-cyproterone-Androcur-et-ses-generiques-et-risque-de-meningiome-Resultats-de-l-enquete-de-pharmacovigilance-Point-d-Information [consult\u00e9 le 12\u00a0f\u00e9v, 2020]."},{"key":"10.1016\/j.revmed.2021.06.011_bib0510","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/annonc\/mdx763","article-title":"Progestin-associated shift of meningioma mutational landscape","volume":"29","author":"Peyre","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0515","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jamaoncol.2016.0891","article-title":"Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784\u00a0Diverse Solid Tumors","volume":"2","author":"Millis","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2017.03.013","article-title":"Dramatic Shrinkage with Reduced Vascularization of Large Meningiomas After Cessation of Progestin Treatment","volume":"101","author":"Kalamarides","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1016\/j.revmed.2021.06.011_bib0525","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00701-018-03782-4","article-title":"Combined hormonal influence of cyproterone acetate and nomegestrol acetate on meningioma: a case report","volume":"161","author":"Champagne","year":"2019","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.revmed.2021.06.011_bib0530","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00701-019-03848-x","article-title":"Spontaneous regression of meningiomas after interruption of nomegestrol acetate: a series of three patients","volume":"161","author":"Passeri","year":"2019","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.revmed.2021.06.011_bib0535","unstructured":"Dossier th\u00e9matique - Lut\u00e9nyl\/Lut\u00e9ran - ANSM n.d. https:\/\/ansm.sante.fr\/dossiers-thematiques\/lutenyl-luteran [consult\u00e9 le 20\u00a0avr, 2021]."},{"key":"10.1016\/j.revmed.2021.06.011_bib0540","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neuchi.2014.11.013","article-title":"Descriptive epidemiology of 13,038\u00a0newly diagnosed and histologically confirmed meningiomas in France: 2006\u20132010","volume":"64","author":"Zouaoui","year":"2018","journal-title":"Neurochirurgie"},{"key":"10.1016\/j.revmed.2021.06.011_bib0545","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/2018.1.FOCUS17752","article-title":"Relationship between tumor location, size, and WHO grade in meningioma","volume":"44","author":"Magill","year":"2018","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.revmed.2021.06.011_bib0550","doi-asserted-by":"crossref","first-page":"i44","DOI":"10.1093\/neuonc\/noy143","article-title":"Imaging and diagnostic advances for intracranial meningiomas","volume":"21","author":"Huang","year":"2019","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0555","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.wneu.2017.01.070","article-title":"Metastatic Atypical and Anaplastic Meningioma: A Case Series and Review of the Literature","volume":"101","author":"Kessler","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1016\/j.revmed.2021.06.011_bib0560","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/neuonc\/nox112","article-title":"PET imaging in patients with meningioma-report of the RANO\/PET Group","volume":"19","author":"Galldiks","year":"2017","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0565","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","article-title":"EANO guidelines for the diagnosis and treatment of meningiomas","volume":"17","author":"Goldbrunner","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0570","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/j.wneu.2019.01.042","article-title":"Meningioma Surgery-Are We Making Progress?","volume":"125","author":"Meling","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.revmed.2021.06.011_bib0575","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2340\/16501977-1795","article-title":"Cognitive and emotional problems in patients after cerebral meningioma surgery","volume":"46","author":"van der Vossen","year":"2014","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.revmed.2021.06.011_bib0580","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s13063-015-1040-3","article-title":"The ROAM\/EORTC-1308\u00a0trial: Radiation versus Observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trial","volume":"16","author":"Jenkinson","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.revmed.2021.06.011_bib0585","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/neuonc\/not330","article-title":"Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review","volume":"16","author":"Kaley","year":"2014","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0590","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/1078-0432.CCR-19-2109","article-title":"Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial","volume":"26","author":"Graillon","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.revmed.2021.06.011_bib0595","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11060-021-03741-7","article-title":"Multimodal management of surgery- and radiation-refractory meningiomas: an analysis of the French national tumor board meeting on meningiomas cohort","volume":"153","author":"Le Van","year":"2021","journal-title":"J Neurooncol"},{"key":"10.1016\/j.revmed.2021.06.011_bib0300","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1200\/JCO.2015.61.6490","article-title":"Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005","volume":"33","author":"Ji","year":"2015","journal-title":"J Clin Oncol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866321005506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866321005506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:45:05Z","timestamp":1759337105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866321005506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0248866321005506"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2021.06.011","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les m\u00e9ningiomes\u00a0: mise au point sur les connaissances actuelles","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2021.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}